GGrantIndex
Sort

326,823 grants matching clinical trial

MD Anderson Cancer Center Prostate Cancer SPORE

$2,228,646
Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Biology & Transplantation of the Human Stem Cell

$2,228,606
Philip McGlave · University Of Minnesota · P01 · FY2010 · CA

THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE

$2,228,496
Mark A Watson · Washington University · U24 · FY2016 · CA

Evaluation of Multi Modality Breast Imaging

$2,228,382
University Of Pennsylvania · P01 · FY2002 · CA

Studies of Autism and Related Disorders

$2,228,127
Susan E. Swedo · National Institute Of Mental Health · Z01 · FY2007 · MH

Clinical and Translational Science Collaborative of Cleveland

$2,228,126
Michael W. Konstan · Case Western Reserve University · KL2 · FY2015 · TR

Recombinant Adeno Associated Virus Vectors for Gene Transfer

$2,228,119
Robert Kotin · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8461

$2,227,911
David P Kelsen · Sloan-Kettering Inst Can Research · N01 · FY2009 · CA

Site-Specific Immune Cell Activation Detection for Improving Individualized Cancer Immunotherapy

$2,227,500
Benjamin M Larimer · University Of Alabama At Birmingham · DP2 · FY2020 · CA

Cancer as a Complex Adaptive System

$2,227,365
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA

The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$2,227,276
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA

Human Artificial Chromosomes for Cancer Research and Functional Genomics

$2,227,197
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Mays Cancer Center at UT Health SA

$2,227,050
Lei Zheng · University Of Texas Hlth Science Center · P30 · FY2025 · CA

Integrative Pathophysiology of Solid Tumors

$2,226,580
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2007 · CA

Protective Mechanisms In Cerebral Ischemia

$2,226,524
John M Hallenbeck · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS

CENTER FOR HUMAN CELL THERAPY

$2,226,371
Leslie Eric Silberstein · Immune Disease Institute, Inc. · U24 · FY2006 · HL

EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2)

$2,226,370
Maurizio Fava · Massachusetts General Hospital · OT2 · FY2023 · NS

IMMUNITY TO MELANOMA VIA DENDRITIC CELLS

$2,226,362
Baylor Research Institute · P01 · FY2002 · CA

DATA ANALYSIS AND STATISTICAL PROGRAMING SUPPORT (BASE CONTRACT) COMPANY: PROSPECTIVE GROUP

$2,226,324
Paul Converti · · N02 · FY2018 · HD

Integrative Pathophysiology of Solid Tumors

$2,226,000
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2006 · CA

R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

$2,225,877
James Wilson · University Of Pennsylvania · N01 · FY2014 · HL

Flavivirus Infections: Pathogenesis and Prevention

$2,225,868
Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · P01 · FY2008 · AI

Thalassemia Clinic Research Network

$2,225,866
Sonja M McKinlay · New England Research Institutes, Inc. · U01 · FY2007 · HL

Synaptic Vesicle Endocytosis

$2,225,755
Ling Gang Wu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Molecular Targeting of Developmental Cancers in Children

$2,225,598
Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA